C4 Therapeutics Statistics
Total Valuation
CCCC has a market cap or net worth of $389.44 million. The enterprise value is $197.53 million.
| Market Cap | 389.44M |
| Enterprise Value | 197.53M |
Important Dates
The last earnings date was Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CCCC has 68.81 million shares outstanding. The number of shares has increased by 39.57% in one year.
| Shares Outstanding | 68.81M |
| Shares Change (YoY) | +39.57% |
| Shares Change (QoQ) | +33.52% |
| Owned by Insiders (%) | 11.58% |
| Owned by Institutions (%) | 75.50% |
| Float | 52.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.44 |
| Forward PS | 27.34 |
| PB Ratio | 1.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.08, with a Debt / Equity ratio of 0.27.
| Current Ratio | 5.08 |
| Quick Ratio | 5.00 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -161.70 |
Financial Efficiency
Return on equity (ROE) is -52.90% and return on invested capital (ROIC) is -41.16%.
| Return on Equity (ROE) | -52.90% |
| Return on Assets (ROA) | -34.00% |
| Return on Capital (ROIC) | -41.16% |
| Revenue Per Employee | $138,179 |
| Profits Per Employee | -$869,476 |
| Employee Count | 145 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CCCC has paid $1.28 million in taxes.
| Income Tax | 1.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +80.89% in the last 52 weeks. The beta is 3.19, so CCCC's price volatility has been higher than the market average.
| Beta (1Y) | 3.19 |
| 52-Week Price Change | +80.89% |
| 50-Day Moving Average | 7.52 |
| 200-Day Moving Average | 4.85 |
| Relative Strength Index (RSI) | 32.67 |
| Average Volume (30 Days) | 2,112,562 |
Short Selling Information
The latest short interest is 10.14 million, so 14.73% of the outstanding shares have been sold short.
| Short Interest | 10.14M |
| Short Previous Month | 9.56M |
| Short % of Shares Out | 14.73% |
| Short % of Float | 19.29% |
| Short Ratio (days to cover) | 4.55 |
Income Statement
In the last 12 months, CCCC had revenue of $20.04 million and -$126.07 million in losses. Loss per share was -$2.37.
| Revenue | 20.04M |
| Gross Profit | 20.04M |
| Operating Income | -135.02M |
| Pretax Income | -124.79M |
| Net Income | -126.07M |
| EBITDA | -116.02M |
| EBIT | -124.03M |
| Loss Per Share | -$2.37 |
Balance Sheet
The company has $261.64 million in cash and $69.72 million in debt, giving a net cash position of $191.92 million or $2.79 per share.
| Cash & Cash Equivalents | 261.64M |
| Total Debt | 69.72M |
| Net Cash | 191.92M |
| Net Cash Per Share | $2.79 |
| Equity / Book Value | 258.28M |
| Book Value Per Share | 3.75 |
| Working Capital | 224.57M |
Cash Flow
In the last 12 months, operating cash flow was -$91.83 million and capital expenditures -$1.12 million, giving a free cash flow of -$92.95 million.
| Operating Cash Flow | -91.83M |
| Capital Expenditures | -1.12M |
| Free Cash Flow | -92.95M |
| FCF Per Share | -$1.36 |
Margins
Gross margin is 100.00%, with operating and profit margins of -673.90% and -629.24%.
| Gross Margin | 100.00% |
| Operating Margin | -673.90% |
| Pretax Margin | -622.85% |
| Profit Margin | -629.24% |
| EBITDA Margin | -579.07% |
| EBIT Margin | -619.02% |
| FCF Margin | -463.91% |
Dividends & Yields
CCCC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.57% |
| Shareholder Yield | -39.57% |
| Earnings Yield | -32.37% |
| FCF Yield | -23.87% |
Analyst Forecast
The average price target for CCCC is $8.88, which is 56.34% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.88 |
| Price Target Difference | 56.34% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 176.05% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CCCC has an Altman Z-Score of -0.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.59 |
| Piotroski F-Score | 2 |